Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07620015

Turkish Version of the Ankle Fracture Outcome of Rehabilitation Measure (A-FORM-TR): A Multi-Centre Validation Study

Ankle fractures are common injuries that can affect a patient's mobility, mood, sleep, and everyday life for months. The Ankle Fracture Outcome of Rehabilitation Measure (A-FORM) is an English-language patient-reported outcome measure developed in Australia to capture this broader rehabilitation experience. No validated Turkish version of A-FORM currently exists. This prospective multi-centre observational study aims to translate the A-FORM into Turkish (A-FORM-TR), culturally adapt it for use in Turkish-speaking patients, and evaluate its psychometric properties. The investigators will recruit 150 adults with a unilateral ankle fracture, treated either surgically or conservatively, from three orthopedic centres in Turkiye and the Turkish Republic of Northern Cyprus. Participants complete the A-FORM-TR together with two established comparator questionnaires (AOFAS Ankle-Hindfoot Score and the Turkish Olerud-Molander Ankle Score). A subset of approximately 50 participants is re-administered the A-FORM-TR after 7 to 14 days to assess test-retest reliability, with a Global Rating of Change item identifying clinically stable patients. Analyses include classical test theory, confirmatory factor analysis, and Rasch measurement analysis.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Kyrenia, Dr. Suat Gunsel Hospital - Department of Orthopaedics and Traumatology, Kyrenia, Cyprus

Loading trial locations.

About this study

Background and Rationale: Ankle fractures are among the most common lower-limb injuries in orthopedic practice. Patient-reported recovery, including physical function, sleep, mood, and social participation, is not adequately captured by traditional clinician-based outcome measures such as the AOFAS Ankle-Hindfoot Score or the Olerud-Molander Ankle Score. The A-FORM, developed by McPhail et al. (2014), is a 15-item, Rasch-calibrated patient-reported outcome measure designed specifically to evaluate the rehabilitation experience after ankle fracture. No validated Turkish-language version currently exists.

Methodological Framework: The study follows the eight-stage cross-cultural adaptation and validation protocol described by Cruchinho et al. (2024), which incorporates the recommendations of Beaton et al. (2000) and the COSMIN framework (Mokkink et al., 2010). Written permission to translate and use the instrument has been granted by Prof. Steven McPhail (Queensland University of Technology).

Translation and Adaptation: Forward translation is carried out by two independent bilingual translators (one faculty member from the Department of English Language and Literature, providing linguistic expertise; one bilingual orthopedic surgeon, providing clinical content expertise). A reconciliation committee produces a synthesised Turkish version, which is then back-translated by two independent translators blinded to the original. A harmonisation expert committee compares the source, forward, and back versions for semantic, idiomatic, experiential, and conceptual equivalence. The harmonised pre-test version is evaluated through cognitive debriefing interviews with 10 to 15 ankle-fracture patients before field testing.

Field Testing: In the field testing phase, 150 adult patients with a radiographically confirmed unilateral ankle fracture (Weber A, B, or C; treated surgically by open reduction and internal fixation or conservatively with cast, walker boot, or functional brace) are enrolled across three orthopedic centres. Patients between 3 weeks and 12 months post-injury are eligible. The A-FORM-TR is administered together with the AOFAS Ankle-Hindfoot Score and the OMAS-TR. A sub-cohort of approximately 50 patients is re-administered the A-FORM-TR at 7 to 14 days, with a Global Rating of Change item used to identify clinically stable patients for the test-retest reliability analysis.

Statistical Analysis Plan: Developed in consultation with the institutional biostatistics team. Internal consistency is assessed by Cronbach's alpha (target greater than or equal to 0.80). Test-retest reliability is assessed by the intraclass correlation coefficient on stable patients (target greater than or equal to 0.90). Structural validity is assessed by confirmatory factor analysis against the a priori structure established by the original developers. Rasch measurement analysis examines item fit, threshold ordering, person separation reliability, person-item targeting, local independence, unidimensionality, and differential item functioning by sex, age group, treatment modality, recruiting centre, and time since injury. Construct validity is assessed via pre-specified hypotheses about correlation patterns with the AOFAS and OMAS-TR. Content validity is assessed via item-level and scale-level Content Validity Index and the Kappa coefficient from the expert committee. Floor and ceiling effects are reported. Responsiveness is not formally evaluated in this initial validation study and is reserved for a planned subsequent longitudinal study. Analyses use SPSS version 26 or later and R (lavaan, psych, eRm, and TAM packages).

Ethics and Registration: Ethics approval is sought from the Girne University Clinical Research Ethics Committee. An institutional permission letter is obtained from Ankara Bilkent City Hospital. Data are handled in accordance with the Turkish Personal Data Protection Law (KVKK No. 6698): pseudonymised, securely stored, and retained for a maximum of 5 years post-publication.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 years or older
  • Radiographically confirmed unilateral ankle fracture (Weber A, B, or C)
  • Either surgical (open reduction and internal fixation) or conservative (cast, walker boot, or functional brace) treatment completed
  • Currently in the rehabilitation phase, 3 weeks to 12 months post-injury
  • Native Turkish speaker, able to read and self-complete a questionnaire
  • Able and willing to provide written informed consent

Exclusion criteria

  • Bilateral ankle fracture
  • Previous ipsilateral ankle fracture or any prior orthopedic surgery on the same ankle
  • Pathological fracture (tumour, metastasis, or other underlying bone pathology)
  • Concurrent significant ipsilateral lower-limb injury (for example pilon fracture, ipsilateral tibial or fibular shaft fracture, ipsilateral femoral or tibial plateau fracture)
  • Polytrauma (significant head, spine, abdominal, or contralateral lower-limb injury affecting function)
  • Cognitive or psychiatric impairment precluding self-completion of the questionnaire
  • Insufficient Turkish literacy
  • Inability to attend a follow-up visit for the test-retest assessment

Treatment and study plan

Primary outcomes

  1. Internal consistency of the A-FORM-TR

    Time frame: At the single study visit (baseline administration)

    Cronbach's alpha coefficient calculated across all scored items of the A-FORM-TR. Target greater than or equal to 0.80.

  2. Test-retest reliability of the A-FORM-TR

    Time frame: 7 to 14 days between the two administrations

    Intraclass correlation coefficient (two-way mixed effects, absolute agreement, single measures) calculated for the A-FORM-TR Summary Score, restricted to patients reporting clinical stability (no change) on a Global Rating of Change item between the two administrations. Target greater than or equal to 0.90.

Secondary outcomes

  1. Rasch model fit of the A-FORM-TR

    Time frame: At the single study visit (baseline administration)

    Rasch measurement analysis serves as the primary framework for evaluating dimensionality and measurement properties of the A-FORM-TR. Examined: item fit (infit and outfit mean-square 0.5 to 1.5), category threshold ordering, person separation reliability (target greater than or equal to 2.0), local independence (residual correlations less than 0.30), unidimensionality (residual principal component analysis first contrast less than 2.0), and differential item functioning by sex, age group, treatment modality, centre, and time since injury. A priori decision rules: items showing substantive misfit will be reviewed for rescoring or removal; disordered thresholds will trigger response category collapsing and re-analysis; items showing significant DIF will be split or removed and the analysis re-run on the modified scale.

  2. Structural validity by confirmatory factor analysis

    Time frame: At the single study visit (baseline administration)

    Confirmatory factor analysis testing the prespecified single-factor (unidimensional) structure established in the original A-FORM development by McPhail et al. (2014). CFA serves as a complementary structural check from a latent-variable perspective alongside the primary Rasch analysis. Model fit assessed by CFI and TLI (target greater than or equal to 0.95), RMSEA (target less than or equal to 0.08), and SRMR (target less than or equal to 0.08).

  3. Construct validity assessed by a priori hypothesis testing

    Time frame: At the single study visit (baseline administration)

    Pearson or Spearman correlations between the A-FORM-TR Summary Score and the AOFAS Ankle-Hindfoot Score and OMAS-TR. Pre-specified hypotheses: H1, strong positive correlation between A-FORM-TR and OMAS-TR (r greater than or equal to 0.60); H2, moderate positive correlation between A-FORM-TR and AOFAS (r between 0.40 and 0.60); H3, the psychosocial items of the A-FORM-TR correlate more weakly with the AOFAS than the physical-function items. Construct validity is considered supported if at least 75 percent of the a priori hypotheses are confirmed.

  4. Content validity of the A-FORM-TR

    Time frame: Pre-testing phase, prior to field testing

    Item-level and scale-level Content Validity Index and the Kappa coefficient of agreement derived from the expert committee evaluation conducted in the pre-testing phase.

  5. Distribution properties: floor and ceiling effects

    Time frame: At the single study visit (baseline administration)

    Percentage of participants scoring at the floor (lowest possible score) and ceiling (highest possible score) of the A-FORM-TR Summary Score. Effects are considered acceptable if less than 15 percent at either extreme.

  6. Known-groups validity by time since injury and treatment modality

    Time frame: At the single study visit (baseline administration)

    Known-groups validity assessed by testing whether A-FORM-TR Summary Scores differ across pre-specified clinical subgroups. Pre-specified hypotheses: H4, patients in the 3-week to 3-month post-injury subgroup will score significantly lower (greater impairment) than patients in the 6- to 12-month subgroup; H5, A-FORM-TR Summary Scores will differ between surgically treated and conservatively treated patients (no a priori directional hypothesis). Analyses by independent-samples t-test or Mann-Whitney U as appropriate, with Cohen's d or effect size reporting. Added in response to peer review feedback from the original instrument developer.

Study contacts

Contact information is provided by the study sponsor or research team.

Utku Gurhan, MD

CONTACT

[email protected]

+90 539 112 6898

Sponsors and collaborators

Lead sponsor

Utku Gürhan

Other

Registry information

Official study title

Cross-Cultural Adaptation and Psychometric Validation of the Turkish Version of the Ankle Fracture Outcome of Rehabilitation Measure (A-FORM-TR): A Multi-Centre Prospective Observational Study

Acronym: A-FORM-TR

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jun 2, 2026
Registry last updated
Jul 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.